CLOT STIFFNESS MEASURED BY SEER SONORHEOMETRY AS A MARKER OF POOR PROGNOSIS IN HOSPITALIZED COVID-19 PATIENTS
Authors:
- Francisco José López-JaimeFLFrancisco José López-Jaime
- Sandra Martín-TéllezSMSandra Martín-Téllez
- Alberto Doblas-MárquezADAlberto Doblas-Márquez
- Ignacio Márquez-GómezIMIgnacio Márquez-Gómez
- José María Reguera-IglesiasJRJosé María Reguera-Iglesias
- Manuel Isidro Muñoz-PérezMMManuel Isidro Muñoz-Pérez
- Adrián MontañoAMAdrián Montaño
Preprint
Abstract
SUMMARY: Background: High incidence of life-threatening thrombotic complications is observed in severely ill COVID-19 patients. D-dimer may help evaluate disease severity and predict outcomes at hospital admission. However, its non-specificity and long analysis times strongly constrain its clinical value. Viscoelastic tests (VET) are widely available rapid point-of-care devices that have been shown to detect a hypercoagulable state (increased clot stiffness and fibrinolysis shutdown) as major contributors of the thrombotic complication in COVID-19. Nevertheless, based on the data obtained so far, definitive conclusions have not been drawn. Objectives: We aim to evaluate the association between VET parameters, standard coagulation tests and inflammation markers assessed in COVID-19 patients at hospital admission with disease severity and outcomes. Patients/Methods: A total of 69 COVID-19 patients requiring hospitalization were included in the study. The pro-inflammatory and pro-thrombotic state was analyzed by a panel of inflammation markers (IL-6, CRP, LDH, ferritin), routine coagulation tests (PT, aPTT, platelet count, fibrinogen, D-dimer) and a SEER sonorheometry VET profile (Quantra ® System). Results: Inflammatory markers IL-6, CRP, LDH and ferritin were elevated in a high percentage of patients (73.6%, 89.2%, 57.1% and 52.4%), as were coagulation-related parameters such as fibrinogen (81.4%) and D-dimer levels (66.2%). Quantra ® analysis revealed increased clot stiffness (CS) in 34.8%, particularly due to increased fibrinogen contribution (FCS) in 63.7%. Increased clot stability to lysis (CSL) was observed in 32.4%. Age > 65 years, elevated values of fibrinogen, D-dimer, LDH, increased clot stiffness and resistance to clot lysis were significantly associated with worsening disease. The Quantra ® FCS parameter showed a particularly high prognostic value in distinguishing patients with severe symptomatology. Conclusion: The global study of hemostasis by the whole blood point-of-care Quantra ® VET system may be a powerful tool for identifying poor prognosis in COVID-19 patients at hospital admission. In particular, FCS measured by Quantra ® could be established as a plausible prognostic marker to aid the clinical management of COVID-19 patients.Keywords
All Related Versions
- Published version: Clinical and Applied Thrombosis/Hemostasis, 28.
This publication has 30 references indexed in Scilit:
- Pulmonary embolism in patients with COVID-19 and value of D-dimer assessment: a meta-analysisEuropean Radiology, 2021
- Elevated levels of IL-6 and CRP predict the need for mechanical ventilation in COVID-19Journal of Allergy and Clinical Immunology, 2020
- Re The source of elevated plasma D‐dimer levels in COVID‐19 infectionBritish Journal of Haematology, 2020
- All those D‐dimers in COVID‐19Journal of Thrombosis and Haemostasis, 2020
- COVID-19 update: Covid-19-associated coagulopathyJournal of Thrombosis and Thrombolysis, 2020
- Prevalence of venous thromboembolism in patients with severe novel coronavirus pneumoniaJournal of Thrombosis and Haemostasis, 2020
- Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumoniaJournal of Thrombosis and Haemostasis, 2020
- Thromboelastography Predicts Thromboembolism in Critically Ill Coagulopathic Patients*Critical Care Medicine, 2019
- Factors Associated With Positive D‐dimer Results in Patients Evaluated for Pulmonary EmbolismAcademic Emergency Medicine, 2010
- D-dimer for the diagnosis of acute venous thromboembolism in the emergency department: a Janus-face markerInternal and Emergency Medicine, 2006